G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients

Namik Kemal University150 enrolled

Overview

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of all participating patients will be determined by two independent investigators before starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools for cancer patients for elderly cancer patients was investigated.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Predicting Chemotherapy Related Toxicity in Elderly Patients

Interventions

Older Patients Receiving ChemotherapyOTHER

No Intervention

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged ≥65 years * Localized or metastatic solid carcinoma diagnosed by histology (any type, any stage) * Starting a new-line (first-line, second-line or third-line) chemotherapy Exclusion Criteria: * Concurrent radiotherapy; * Simultaneous immunotherapy * Impaired language * Cognitive function leading to inability to complete assessments.

Locations (1)

Tekirdağ Namık Kemal University

Tekirdağ, Turkey (Türkiye)

Outcomes

Primary Outcomes

G8 (Geriatric 8) screening tool measurement

Time frame: 15-30 minutes

CARG (Cancer and Aging Research Group) chemotherapy toxicity score measurement

Time frame: 30-60 minutes

VES-13 (Vulnerable Elders Survey-13) measurement

Time frame: 30-60 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.